P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII | NASDAQ
Chart Builder DCF Calculator
$7.52
-$0.08 (-1.05%)
At close: Sep 22, 2026, 4:00 PM ET
$7.52
$0 (0.00%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$24.9M
Enterprise Value
$133.9M
Beta
1.62
Average Volume
1.29M
Shares Outstanding (Diluted)
3.36M
Shares Change YoY
2.91%
Institutional Ownership
7.41%
Exchange
NASDAQ
ISIN
US7444132044

Price Performance

Price Change 1M
-26.4%
Price Change 3M
-36.6%
Price Change 6M
144.4%
Price Change YTD
117.1%
Price Change 1Y
-9.0%
Price Change 3Y
-90.0%
Price Change 5Y
-98.5%
1M CAGR (ann.)
-34.4%
1Y CAGR (ann.)
0.4%
5Y CAGR (ann.)
-56.6%
All-Time CAGR
-53.3%

Valuation

PE Ratio
-0.23
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
-0.01
PS Ratio
0.02
Forward PS
0.00
PB Ratio
0.34
P/FCF Ratio
-0.19
P/Adj. FCF Ratio
-0.18
P/OCF Ratio
-0.20
EV/Sales
0.09
EV/EBIT
-0.80
EV/EBITDA
-1.63
EV/FCF
-1.03
Earnings Yield
-434.2%
FCF Yield
-523.8%
Adj. FCF Yield
-540.7%

Financial Health

Net Debt
$98.58M
Total Debt
$130.27M
Cash & Short-Term Investments
$21.27M
Total Assets
$654.39M
Current Ratio
0.46
Quick Ratio
0.46
Debt / Equity Ratio
1.80
Debt / EBITDA
-1.58
Debt / FCF
-1.00
OCF / Debt
-1.00
Interest Coverage
-2.44
Altman Z-Score
-0.28
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
31.6%
Operating Profit Margin
-9.9%
EBITDA Margin
-5.5%
Net Profit Margin
-6.5%
FCF Margin
-8.7%
Adj. FCF Margin
-9.0%
SBC / Revenue
0.3%
SBC Impact (per share)
-3.2%

Returns

Return on Assets
-15.0%
Return on Equity
160.5%
Return on Invested Capital
-51.7%
Return on Capital Employed
-55.9%
Return on Tangible Assets
-48.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
9.7%
Revenue CAGR 5Y
22.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-0.9%
EPS CAGR 5Y
64.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-36.5%
FCF CAGR 5Y
1.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
4
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$3.96
EPS Growth Est (next Q)
-59.0%
Revenue Est (next Q)
$385.15M
Revenue Growth Est (next Q)
11.6%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$18.50
Price Target Upside
143.4%

Cash Flow

Operating Cash Flow
$-130.52M
Free Cash Flow
$-130.4M
Adj. Free Cash Flow
$-134.63M
FCF Per Share
-$38.79
OCF Per Share
-$38.82
OCF/S Ratio
-8.7%

Income Statement

Revenue
$1.5B
Gross Profit
$484.23M
Operating Income
$-148.63M
EBITDA
$-82.31M
Net Income
$-98.44M
EPS (Diluted)
-$33
Revenue / Employee
$4.7M
Profit / Employee
$-307.62K
Employees
320

© 2026 bestshares.com. All rights reserved.